EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fractional-order optimal control for personalized chemotherapy scheduling in hematological malignancies

Carolyne Onyancha, Joash Kerongo, Fred Monari, Evans Mogoi

SCIENCE MUNDI · 20.08.2026 · 6 (2) · 207-227

DOI: 10.51867/scimundi.6.2.18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SCIENCE MUNDI, online erschienen am 20.08.2026. Verfasst von Carolyne Onyancha und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical management of hematological malignancies requires a delicate balance between tumor cytotoxicity, immune preservation, and toxicity. Traditional integer-order models fail to capture the memory-dependent dynamics of cancer-immune interactions, leading to suboptimal dosing schedules. We present a comprehensive optimal control framework based on fractional-order differential equations that incorporates memory effects through Caputo derivatives with patient-specific parameter α ∈ (0,1]. The model tracks tumor cells, immune response, normal tissue damage, and drug concentration. We formulate a quadratic optimal control problem balancing tumor burden, drug exposure, and normal-cell preservation. The resulting personalized schedules vary dramatically with α: strong memory (α = 0.5) patients benefit from pulsed therapy (5 days on / 9 days off, 4 cycles), while weak memory (α = 0.9) require metronomic continuous low-dose therapy. The framework reduces total cost by 39–63% versus no treatment and improves immune preservation by 27–36% over standard CHOP/R-CHOP. Validation against 8 cohorts (n = 1,020 patients) yields mean error 2.4% (95% CI: 1.8–3.0%) and R² = 0.96. The Pareto "knee" occurs at tumor weight A = 0.5–0.7 (71–82% reduction with acceptable toxicity). Monthly re-optimisation provides the best clinical benefit-to-burden trade-off. Robustness analysis shows α is the most robust parameter (4–6% performance drop for ±10% perturbation), while δC requires re-optimisation. Cost-effectiveness analysis shows optimal strategies are dominant (lower cost, higher QALYs) for strong-memory patients. A practical 7-day clinical workflow is provided, with open-source code for implementation. These results demonstrate that fractional-order modelling captures essential biological memory effects, enabling truly personalised, clinically actionable chemotherapy schedules.

Zitieren

APA

Onyancha, C., Kerongo, J., Monari, F., & Mogoi, E. (2026). Fractional-order optimal control for personalized chemotherapy scheduling in hematological malignancies. SCIENCE MUNDI, 6(2), 207-227. https://doi.org/10.51867/scimundi.6.2.18

Vancouver

Onyancha C, Kerongo J, Monari F, Mogoi E. Fractional-order optimal control for personalized chemotherapy scheduling in hematological malignancies. SCIENCE MUNDI. 2026;6(2):207-227. doi:10.51867/scimundi.6.2.18

BibTeX
@article{Onyancha2026,
  author = {Onyancha, Carolyne and Kerongo, Joash and Monari, Fred and Mogoi, Evans},
  title = {Fractional-order optimal control for personalized chemotherapy scheduling in hematological malignancies},
  journal = {SCIENCE MUNDI},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {207--227},
  doi = {10.51867/scimundi.6.2.18}
}
Kostenlos starten →